Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
For multiinjection doses, use different sites for each injection on the same day
Quick Takeaways AOD 9604 directly targets fat cell metabolism without affecting appetite or growth hormone pathways Tirzepatide works primarily through appetite suppression and glucose control as a dual GLP-1/GIP agonist Tirzepatide has robust human clinical trial data showing over 20% body weight reduction
When combined with tesofensine's reuptake inhibition, the result is excessive sympathetic nervous system activation
Photograph each new vial upon receipt to establish a baseline appearance for comparison
US$ 21.47
US$ 25.74
US$ 27.82
US$ 20.16
